/

Sociétés

AS

Sociétés

ASABYS

Ce que nous écrivons

Auto / AutomobileIngénierieSantéSanté PubliqueUniversité

25 communiqués de presse

Voir tous les communiqués de presse

Press Release cover image

09/12/2025

Santé

Santé Publique

INBRAIN Neuroelectronics Appoints Scott Huennekens as Chairman of the Board - Asabys Partners

Source

1.00

0

Press Release cover image

17/11/2025

Santé

Santé Publique

Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease - Asabys Partners

Source

1.00

0

Press Release cover image

04/11/2025

Économie

Économie internationale

Santé

Sports Divers

Qida raises €37 million to continue improving the quality of life of the senior segment at home - Asabys Partners

Source

1.00

0

Press Release cover image

14/10/2025

Santé

Oncologie

Santé Publique

Ona Therapeutics, a portfolio company of Asabys Partners and Alta Life Sciences, appoints Dr. Antoine Yver as Chair of the Board to accelerate its ADC programs towards clinical development - Asabys Partners

Source

1.00

0

Press Release cover image

10/09/2025

Santé

Santé Publique

Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac® - Asabys Partners

Source

1.00

0

Press Release cover image

11/06/2025

Santé

Santé Publique

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines - Asabys Partners

Source

1.00

0

Press Release cover image

29/04/2025

Université

Santé

Santé Publique

Deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection - Asabys Partners

Source

1.00

0

Press Release cover image

17/04/2025

Université

Santé

Santé Publique

Three Asabys-Backed Biotechs Featured in Nature, Showcasing Spain’s Scientific Innovation - Asabys Partners

Source

1.00

0

01/04/2025

Université

Santé

Santé Publique

Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair - Asabys Partners

Source

1.00

0

24/03/2025

Université

Santé

Santé Publique

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round - Asabys Partners

Source

1.00

0

Followers

0

Compatibilité

0